Prediction of COVID-19 severity from clinical and biochemical markers: a single-center study from Saudi Arabia
H.M. Alshanbari, W. Sami, T. Mehmood, M. Aboud, T. Alanazi, M.A Hamza, I. Brema, B. Alosaimi Department of Mathematical Sciences, College of Science, Princess Nourah bint Abdulrahman University, P.O.Box 84428, Riyadh 11671, Saudi Arabia. w.mahmood@mu.edu.sa
OBJECTIVE: It is known that the severity of COVID-19 is linked to the prognosis of patients; therefore, an early identification is required for patients who are likely to develop severe or critical COVID-19 disease. The purpose of this study is to propose a statistical method for identifying the severity of COVID-19 disease by using clinical and biochemical laboratory markers.
PATIENTS AND METHODS: A total of 48 clinically and laboratory-confirmed cases of COVID-19 were obtained from King Fahad Hospital, Medina (KFHM) between 27th April 2020 to 25th May 2020. The patients’ demographics and severity of COVID-19 disease were assessed using 39 clinical and biochemical features. After excluding the demographics, 35 predicting features were included in the analysis (diabetes, chronic disease, viral and bacterial co-infections, PCR cycle number, ICU admission, clot formation, cardiac enzymes elevation, hematology profile, sugar levels in the blood, as well as liver and kidney tests, etc.). Logistic regression, stepwise logistic regression, L-2 logistic regression, L-2 stepwise logistic regression, and L-2 best subset logistic regression were applied to model the features. The consistency index was used with kernel Support-Vector Machines (SVM) for the identification of associated markers.
RESULTS: L-2 best subset logistic regression technique outperformed all other fitted models for modeling COVID-19 disease severity by achieving an accuracy of 88% over the test data. Consistency index over L-2 best subset logistic regression identified 14 associated markers that can best predict the COVID-19 severity among COVID-19 patients.
CONCLUSIONS: By combining a variety of laboratory markers with L-2 best subset logistic regression, the current study has proposed a highly accurate and clinically interpretable model of predicting COVID-19 severity.
Free PDF Download
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
H.M. Alshanbari, W. Sami, T. Mehmood, M. Aboud, T. Alanazi, M.A Hamza, I. Brema, B. Alosaimi
Prediction of COVID-19 severity from clinical and biochemical markers: a single-center study from Saudi Arabia
Eur Rev Med Pharmacol Sci
Year: 2022
Vol. 26 - N. 7
Pages: 2592-2601
DOI: 10.26355/eurrev_202204_28497